search
Back to results

A Waiting Room-Delivered Video to Enhance Clinical Outcomes Among Persons Living With HIV (TCOM)

Primary Purpose

HIV Infections

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Taking Care of Me Video
Sponsored by
Centers for Disease Control and Prevention
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for HIV Infections

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

HIV/AIDS treatment facility inclusion: The participating treatment facilities will have a combined total of at least 2,700 monthly patient visits during the study period. Each of the HIV/AIDS treatment facilities meets the following inclusion criteria:

  1. located in a jurisdiction with high AIDS prevalence;
  2. managing more than 500 unique HIV-positive patients annually;
  3. serving minority persons such that minimally 55% of the clinic population is African-American and Hispanic/Latino;
  4. at least 163 patients have unsuppressed viral load;
  5. utilizing an electronic medical record (EMR) system; and
  6. not participating in another behavioral intervention research project during the historical comparison data period (August 2015 through May 2016) or during the 10-month intervention period (June 2016 through March 2017).

Exclusion Criteria:

-

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    Intervention

    Comparison

    Arm Description

    29-minute clinic waiting room video intervention that includes three vignettes and a 2-part animation sequence about main characters who model overcoming challenges to optimal HIV care. The video was played on continuous loop in recognition of typically short patient wait times. Waiting room posters used images from the video to direct patients' attention to the video and reinforce prevention messages.

    Historical comparison condition. Patients were exposed to standard waiting room environment (absent of intervention video and posters).

    Outcomes

    Primary Outcome Measures

    Antiretroviral therapy (ART) medication adherence (suppression level)
    Adherence was measured by whether viral load suppression (<200 RNA copies/mL) was achieved
    Antiretroviral therapy (ART) medication adherence (undetectable level)
    Adherence was measured by whether viral load suppression (<50 RNA copies/mL) was achieved

    Secondary Outcome Measures

    Treatment initiation
    Treatment initiation was measured by a patient's receipt of an ART prescription
    Retention in HIV medical care
    Measured by an adaptation of the Health Resources and Services Administration's (HRSA) definition in the Annual Ryan White HIV/AIDS Program Services Report

    Full Information

    First Posted
    April 16, 2018
    Last Updated
    April 16, 2018
    Sponsor
    Centers for Disease Control and Prevention
    Collaborators
    Sentient Research, UCLA David Geffen School of Medicine and Fielding School of Public Health, Denver STD Prevention Training Center, Denver Public Health Department, California State University, Long Beach, Education Development Center, Inc.
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03508310
    Brief Title
    A Waiting Room-Delivered Video to Enhance Clinical Outcomes Among Persons Living With HIV
    Acronym
    TCOM
    Official Title
    A Waiting Room-Delivered Video to Enhance Antiretroviral Therapy Readiness, Adherence, and Retention in Care for Minority Persons Living With HIV Infection
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2018
    Overall Recruitment Status
    Completed
    Study Start Date
    June 1, 2016 (Actual)
    Primary Completion Date
    March 30, 2017 (Actual)
    Study Completion Date
    May 17, 2017 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Centers for Disease Control and Prevention
    Collaborators
    Sentient Research, UCLA David Geffen School of Medicine and Fielding School of Public Health, Denver STD Prevention Training Center, Denver Public Health Department, California State University, Long Beach, Education Development Center, Inc.

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this project is to beta-test a brief waiting room video intervention that promotes early initiation of antiretroviral treatment among treatment-naïve HIV-positive patients, adherence to antiretroviral treatment and retention in care among HIV-positive patients currently on therapy, sexual risk reduction tailored to HIV-positive persons, and patient-initiated discussion of these topics with their health providers. The video is currently being created, and will be ready for beta-testing by June 1, 2016. Results of the beta-testing will be used to refine and improve the video before dissemination to HIV/AIDS treatment facilities nationally. This video project is being funded by the Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention (DHAP).
    Detailed Description
    The overall goal of this study is to beta-test the waiting room video in three HIV/AIDS treatment facilities in different US jurisdictions with high AIDS prevalence. These results will be used to refine the video and to increase its effectiveness among minority persons living with HIV infection. The beta-testing will consist of: 1) unobtrusive observations of waiting room patients for one day at each facility and 2) de-identified, existing patient medical data abstracted from each facility's electronic medical record (EMR) system to investigate outcomes relevant to HIV medication adherence and retention in care.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    HIV Infections

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Quasi-experimental design, in which the intervention condition (i.e., video and posters) was implemented for 10 months and the historical comparison condition (i.e., standard waiting room environment) was the prior 10-month period.
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    4003 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Intervention
    Arm Type
    Experimental
    Arm Description
    29-minute clinic waiting room video intervention that includes three vignettes and a 2-part animation sequence about main characters who model overcoming challenges to optimal HIV care. The video was played on continuous loop in recognition of typically short patient wait times. Waiting room posters used images from the video to direct patients' attention to the video and reinforce prevention messages.
    Arm Title
    Comparison
    Arm Type
    No Intervention
    Arm Description
    Historical comparison condition. Patients were exposed to standard waiting room environment (absent of intervention video and posters).
    Intervention Type
    Other
    Intervention Name(s)
    Taking Care of Me Video
    Intervention Description
    The video's conceptual framework incorporates Social Cognitive Theory, Information-Motivation-Behavioral Skills model, and Social Action Theory, which together address cognitive and behavioral factors related to study outcomes. Storylines embedded prevention messages aimed at increasing treatment initiation (n=9), medication adherence (n=35), retention in care (n=22), partner protection (n=12), and communication with health care providers (n=7).
    Primary Outcome Measure Information:
    Title
    Antiretroviral therapy (ART) medication adherence (suppression level)
    Description
    Adherence was measured by whether viral load suppression (<200 RNA copies/mL) was achieved
    Time Frame
    By 6 months (183 days) after the patient's index (first) visit to the clinic
    Title
    Antiretroviral therapy (ART) medication adherence (undetectable level)
    Description
    Adherence was measured by whether viral load suppression (<50 RNA copies/mL) was achieved
    Time Frame
    By 6 months (183 days) after the patient's index (first) visit to the clinic
    Secondary Outcome Measure Information:
    Title
    Treatment initiation
    Description
    Treatment initiation was measured by a patient's receipt of an ART prescription
    Time Frame
    on, before, or within 7 days after, their index visit, as documented by OAMC visits in patient EMRs.
    Title
    Retention in HIV medical care
    Description
    Measured by an adaptation of the Health Resources and Services Administration's (HRSA) definition in the Annual Ryan White HIV/AIDS Program Services Report
    Time Frame
    2 or more clinic visits for any reason at least 90 days apart in the past year divided by all active clients who had had at least one such visit in the past year

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: HIV/AIDS treatment facility inclusion: The participating treatment facilities will have a combined total of at least 2,700 monthly patient visits during the study period. Each of the HIV/AIDS treatment facilities meets the following inclusion criteria: located in a jurisdiction with high AIDS prevalence; managing more than 500 unique HIV-positive patients annually; serving minority persons such that minimally 55% of the clinic population is African-American and Hispanic/Latino; at least 163 patients have unsuppressed viral load; utilizing an electronic medical record (EMR) system; and not participating in another behavioral intervention research project during the historical comparison data period (August 2015 through May 2016) or during the 10-month intervention period (June 2016 through March 2017). Exclusion Criteria: -
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Mary S. Neumann, PhD
    Organizational Affiliation
    Centers for Disease Control and Prevention
    Official's Role
    Principal Investigator
    First Name & Middle Initial & Last Name & Degree
    Aaron Plant, MPH
    Organizational Affiliation
    Sentient Research
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes
    IPD Sharing Plan Description
    When appropriate, data sets will be made available to interested researchers following discussion with study team.
    IPD Sharing Time Frame
    To be determined
    IPD Sharing Access Criteria
    To be determined
    Citations:
    PubMed Identifier
    30289884
    Citation
    Neumann MS, Plant A, Margolis AD, Borkowf CB, Malotte CK, Rietmeijer CA, Flores SA, O'Donnell L, Robilotto S, Myint-U A, Montoya JA, Javanbakht M, Klausner JD. Effects of a brief video intervention on treatment initiation and adherence among patients attending human immunodeficiency virus treatment clinics. PLoS One. 2018 Oct 5;13(10):e0204599. doi: 10.1371/journal.pone.0204599. eCollection 2018.
    Results Reference
    derived

    Learn more about this trial

    A Waiting Room-Delivered Video to Enhance Clinical Outcomes Among Persons Living With HIV

    We'll reach out to this number within 24 hrs